Search Results
Results found for "Domain Therapeutics"
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological tools and potential therapeutic
- irreversible drugs post 2 | Dr. GPCR Ecosystem
The result: inconsistent exposure, patchy activity, and sometimes, outright therapeutic failure.
- Flash News: Your Hub for GPCR Insights and Scientific Conference Programs
This is the kind of advance that matters for anyone building tools, assays, or therapeutics around receptor Michelle describes how reading those early papers on lipid-rich domains and GPCR–G protein compartmentalization translational impact — giving us new ways to think about receptor pharmacology, biased agonism, and therapeutic lesson: Target depletion vs. replenishment dynamics — how offset rates control exposure windows, shape therapeutic The result: inconsistent exposure, patchy activity, and sometimes, outright therapeutic failure.
- Dr. Fiona Marshall | Dr. GPCR Ecosystem
As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
She has advanced the use of computational methods to meet the challenges of designing therapeutics with
- Dr. Amynah Pradhan | Dr. GPCR Ecosystem
Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic
- GPCR Courses
Measuring and understanding bias helps design drugs that maximize therapeutic benefits while minimizing See- The Importance of Pharmacologic Assays Lecture 2: Drug Disposition in Physiological Tissues as a Therapeutic Lecture 4: Unconventional GPCR Ligands as Drugs Lecture 5: Unique Exploitable GPCR-Ligand Behaviors for Therapeutic
- Dr. Demet Araç | Dr. GPCR Ecosystem
Demet's research on the gain domain of adhesion GPCRs started during his postdoctoral studies and continued
- Dr. Brian Arey | Dr. GPCR Ecosystem
His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
orphan GPCRs from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic
- Dr. Aaron Sato | Dr. GPCR Ecosystem
record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics
- Dr. Brian Arey | Dr. GPCR Ecosystem
His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics
- Dr. Adriano Marchese | Dr. GPCR Ecosystem
The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic
- Dr. Kevin Pfleger | Dr. GPCR Ecosystem
Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics
- Affiliate Policy | Dr. GPCR Ecosystem
GPCR name (including misspells and variations) as a sub-domain or sub-folder.
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
- Dr. Timo De Groof | Dr. GPCR Ecosystem
nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics
- Dr. Michael Feigin | Dr. GPCR Ecosystem
Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic
- Applying Pharmacology to Drug Discovery
What makes each drug type unique to therapeutic pharmacology? 3.
- Dr. Prasenjit Saha | Dr. GPCR Ecosystem
receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations
- Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem
neuronal circuits — insights that inform next-generation functional assay development and translational therapeutic
- Celtarys Research | Dr. GPCR Ecosystem
Celtarys’ cutting-edge fluorescent ligand technology and accelerate the development of GPCR-targeted therapeutics accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic
- Dr. Michel Bouvier | Dr. GPCR Ecosystem
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- Session VIII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
GPCRs in the regulation of physiologic/pathologic function in the heart in an effort to uncover novel therapeutic
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic

























